Fozia Saleem

Fozia Saleem has over 20 years of work experience in various industries. Fozia is currently the Chief Executive Officer at Magnitude Biosciences Ltd, a position they have held since 2022. Prior to this, Fozia worked at Broughton from 2019 to 2022, where they held multiple roles including Director of Product Development Services and Director of Scientific Affairs & Programme Management. In these roles, they were responsible for driving strategy, business development, and marketing, as well as delivering pre-market medical dossiers for regulatory approval. Fozia also contributed to the growth and transformation of Broughton, leading organizational redesign and building a high-performing multifunctional team. Before joining Broughton, Fozia worked at Nicoventures Ltd from 2012 to 2019, where they held the position of Senior Research & Development Manager and Products Testing Manager. At Nicoventures, they managed global cross-functional teams, developed product concepts, and implemented processes for marketing claims substantiation. Fozia began their career at British American Tobacco as a Project Manager and Management Trainee. Fozia also worked as a Research Technician at GlaxoSmithKline. Overall, Fozia has a diverse background in leadership, product development, project management, and research.

Fozia Saleem has an impressive education history. Fozia obtained their Bachelor of Science with First-Class Honors in Pharmacology with Industrial Experience from The University of Manchester, which they completed from 2000 to 2004. Subsequently, they pursued their passion for research and furthered their studies at The University of Edinburgh. There, they successfully completed their Doctor of Philosophy (PhD) in Molecular Physiology, spanning from 2004 to 2008. Fozia's educational background showcases their strong foundation in both the practical and theoretical aspects of Pharmacology and Molecular Physiology.